World Journal of Hepatology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Homepage

Online Submission

Number of total visits: 2407132

Number of visits today: 264

Number of downloads: 1581139

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Zhang C, Wang X, Fang D, Xu P, Mo X, Hu C, Abdelatty A, Wang M, Xu H, Sun Q, Zhou G, She J, Xia J, Hui KM, Xia H. STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway. Theranostics 2021;11:2108-22. [PMID: 33500714 DOI: 10.7150/thno.48112] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]

For:

Zhang C, Wang X, Fang D, Xu P, Mo X, Hu C, Abdelatty A, Wang M, Xu H, Sun Q, Zhou G, She J, Xia J, Hui KM, Xia H. STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway. Theranostics 2021;11:2108-22. [PMID: 33500714 DOI: 10.7150/thno.48112] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]

Number	Citing Articles
1	Li Z, Zhang Y, Zhou Y, Wang F, Yin C, Ding L, Zhang S. Tanshinone IIA suppresses the progression of lung adenocarcinoma through regulating CCNA2-CDK2 complex and AURKA/PLK1 pathway. Sci Rep 2021;11:23681. [PMID: 34880385 DOI: 10.1038/s41598-021-03166-2] [Reference Citation Analysis]
2	Qin S, Ning M, Liu Q, Ding X, Wang Y, Liu Q. Knockdown of long non-coding RNA CDKN2B-AS1 suppresses the progression of breast cancer by miR-122-5p/STK39 axis. Bioengineered 2021;12:5125-37. [PMID: 34374638 DOI: 10.1080/21655979.2021.1962685] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3	Xu H, Ma Z, Mo X, Chen X, Xu F, Wu F, Chen H, Zhou G, Xia H, Zhang C. Inducing Synergistic DNA Damage by TRIP13 and PARP1 Inhibitors Provides a Potential Treatment for Hepatocellular Carcinoma. J Cancer 2022;13:2226-37. [PMID: 35517402 DOI: 10.7150/jca.66020] [Reference Citation Analysis]
4	Hao X, Zhang Y, Lu Y, Han G, Rong D, Sun G, Sun G, Tang W, Wu J, Wang X. STK39 enhances the progression of Cholangiocarcinoma via PI3K/AKT pathway. iScience 2021;24:103223. [PMID: 34746696 DOI: 10.1016/j.isci.2021.103223] [Reference Citation Analysis]
5	He Q, Fan B, Du P, Jin Y. Construction and Validation of Two Hepatocellular Carcinoma-Progression Prognostic Scores Based on Gene Set Variation Analysis. Front Cell Dev Biol 2022;10:806989. [DOI: 10.3389/fcell.2022.806989] [Reference Citation Analysis]
6	Wang J, Fan Z, Li J, Yang J, Liu X, Cheng J. Transcription factor specificity protein 1-mediated Serine/threonine kinase 39 upregulation promotes the proliferation, migration, invasion and epithelial-mesenchymal transition of hepatocellular carcinoma cells by activating the transforming growth factor-β1 /Smad2/3 pathway. Bioengineered 2021;12:3566-77. [PMID: 34281492 DOI: 10.1080/21655979.2021.1947939] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7	Huang Z, Wang S, Zhang HJ, Zhou YL, Shi JH. SMOX expression predicts the prognosis of non-small cell lung cancer. Ann Transl Med 2021;9:1048. [PMID: 34422960 DOI: 10.21037/atm-21-998] [Reference Citation Analysis]